Skip to main content

Featured

Greece Faces Mounting Social Strain as 2.8 Million Residents Risk Poverty

                                        Athens, Greece Greece is once again confronting a troubling social reality: an estimated 2.8 million people—more than a quarter of the country’s population—are now at risk of poverty or social exclusion. Despite signs of economic recovery in recent years, the benefits have not reached everyone, leaving many households struggling to keep up with rising living costs, stagnant wages, and persistent unemployment. The latest figures highlight widening inequality, particularly among young people, single‑parent families, and the long‑term unemployed. Inflation has intensified the pressure, eroding purchasing power and pushing vulnerable groups closer to the edge. Social organizations warn that the situation is becoming unsustainable, with increasing demand for food aid, housing support, and community services. While the government ha...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment